Strosberg J - Search Results

1

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.

Hobday TJ, Qin R, Reidy-Lagunes D, Moore MJ, Strosberg J, Kaubisch A, Shah M, Kindler HL, Lenz HJ, Chen H, Erlichman C. Hobday TJ, et al. Among authors: strosberg j. J Clin Oncol. 2015 May 10;33(14):1551-6. doi: 10.1200/JCO.2014.56.2082. Epub 2014 Dec 8. J Clin Oncol. 2015. PMID: 25488966 Free PMC article. Clinical Trial.

2

Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut.

Strosberg J, Gardner N, Kvols L. Strosberg J, et al. Neuroendocrinology. 2009;89(4):471-6. doi: 10.1159/000197899. Epub 2009 Jan 28. Neuroendocrinology. 2009. PMID: 19174605

3

Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.

Strosberg J, Nasir A, Coppola D, Wick M, Kvols L. Strosberg J, et al. Hum Pathol. 2009 Sep;40(9):1262-8. doi: 10.1016/j.humpath.2009.01.010. Epub 2009 Apr 14. Hum Pathol. 2009. PMID: 19368957

4

Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series.

Saranga-Perry V, Morse B, Centeno B, Kvols L, Strosberg J. Saranga-Perry V, et al. Among authors: strosberg j. Neuroendocrinology. 2013;97(4):318-21. doi: 10.1159/000345938. Epub 2013 Jan 3. Neuroendocrinology. 2013. PMID: 23296364

5

Neuroendocrine tumours of the small intestine.

Strosberg J. Strosberg J. Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):755-73. doi: 10.1016/j.bpg.2012.12.002. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582917 Review.

6

Cytoplasmic Clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stage.

Henderson-Jackson EB, Nasir A, Chen DT, Nandyala P, Djeu J, Strosberg J, Kvols L, Coppola D. Henderson-Jackson EB, et al. Among authors: strosberg j. Pancreas. 2013 Aug;42(6):967-70. doi: 10.1097/MPA.0b013e318293734b. Pancreas. 2013. PMID: 23770713 Free PMC article.

7

Evolving treatment strategies for management of carcinoid tumors.

Strosberg J. Strosberg J. Curr Treat Options Oncol. 2013 Sep;14(3):374-88. doi: 10.1007/s11864-013-0246-4. Curr Treat Options Oncol. 2013. PMID: 23892588 Review.

8

Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs).

Strosberg J. Strosberg J. Gastrointest Cancer Res. 2013 Jul;6(4 Suppl 1):S10-2. Gastrointest Cancer Res. 2013. PMID: 24312683 Free PMC article.

9

Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.

Daud AI, Ashworth MT, Strosberg J, Goldman JW, Mendelson D, Springett G, Venook AP, Loechner S, Rosen LS, Shanahan F, Parry D, Shumway S, Grabowsky JA, Freshwater T, Sorge C, Kang SP, Isaacs R, Munster PN. Daud AI, et al. Among authors: strosberg j. J Clin Oncol. 2015 Mar 20;33(9):1060-6. doi: 10.1200/JCO.2014.57.5027. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605849 Clinical Trial.

10

The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.

Cives M, Strosberg J. Cives M, et al. Among authors: strosberg j. Drugs. 2015 May;75(8):847-58. doi: 10.1007/s40265-015-0397-7. Drugs. 2015. PMID: 25911185 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters